March 28, 2018 / 4:21 PM / in 3 months

BRIEF-Inventiva Says Lanifibranor Carcinogenicity Studies Are Progressing As Planned

March 28 (Reuters) - INVENTIVA SA:

* LANIFIBRANOR CARCINOGENICITY STUDIES: PROGRESSING AS PLANNED

* LANIFIBRANOR CARCINOGENICITY STUDIES: INTERIM RESULTS IN RATS INDICATE NO COMPOUND RELATED URINARY BLADDER TUMORS

* 104-WEEK IN-LIFE PERIOD COMPLETED

* FINAL PEER-REVIEWED RESULTS EXPECTED FOR BOTH SPECIES BY END OF Q2 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below